483 King Pharmaceuticals. Jan 2010

483 King Pharmaceuticals. Jan 2010

Thomas Arista FDA, Rebecca Dombrowski FDA$119.00 - Available Now

FDA investigators audited the King Pharmaceuticals. - Rochester, MI, United States facility and issued inspectional observations (via FDA 483) on 19 Jan 2010.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Jan 2010
  • Location: Rochester, United States
  • FEI: 1876582
Add To Cart